Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options. 2015

Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
Department of Emergency Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important cause of resistance of Gram-negative bacteria. The genes encoding for the acquired carbapenemases are associated with a high potential for dissemination. In addition, infections due to Gram-negative bacteria with acquired carbapenemase production would lead to high clinical mortality rates. Of the acquired carbapenemases, Klebsiella pneumoniae carbapenemase (Ambler class A), Verona integron-encoded metallo-β-lactamase (Ambler class B), New Delhi metallo-β-lactamase (Ambler class B) and many OXA enzymes (OXA-23-like, OXA-24-like, OXA-48-like, OXA-58-like, class D) are considered to be responsible for the worldwide resistance epidemics. As compared with monotherapy with colistin or tigecycline, combination therapy has been shown to effectively lower case-fatality rates. However, development of new antibiotics is crucial in the present pandrug-resistant era.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D016905 Gram-Negative Bacterial Infections Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method. Bacterial Infections, Gram-Negative,Infections, Gram-Negative Bacterial,Bacterial Infection, Gram-Negative,Gram Negative Bacterial Infections,Gram-Negative Bacterial Infection,Infection, Gram-Negative Bacterial
D018440 beta-Lactam Resistance Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets. beta-Lactam Resistant,beta-Lactamase Resistance,beta-Lactamase Resistant,Resistance, beta-Lactamase,Resistant, beta-Lactamase,beta Lactam Resistance,beta Lactam Resistant,beta Lactamase Resistance,beta Lactamase Resistant

Related Publications

Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
February 2012, Nihon rinsho. Japanese journal of clinical medicine,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
February 2021, Iranian journal of microbiology,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
June 2015, Journal of medical microbiology,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
May 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
July 2018, International journal of antimicrobial agents,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
September 2020, Emerging infectious diseases,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
June 2021, Journal of global antimicrobial resistance,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
August 2014, International journal of antimicrobial agents,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
January 2025, Frontiers in microbiology,
Shio-Shin Jean, and Wen-Sen Lee, and Carlos Lam, and Chin-Wang Hsu, and Ray-Jade Chen, and Po-Ren Hsueh
March 2019, European journal of microbiology & immunology,
Copied contents to your clipboard!